GE Healthcare and Thermo Fisher Scientific make Headlines with Newest Acquisition Announcement


GE Healthcare was in the news recently with its acquisition of Thermo Fischer Scientific’s cell culture media and sera, and gene modulation and magnetic business.  As the press release states this adds to GE’s “leadership in medical diagnostic technology includes its $4 billion Life Sciences business, which delivers innovative products and services for the fast-growing diagnostics, research and biopharmaceutical manufacturing sectors.” View the Press Release here.

GE’s specific capabilities in biomanufacturing will be on display at INTERPHEX, March 18-20.

“GE Healthcare Life Sciences provides tools and technologies, solutions and expertise which enable the biopharmaceutical industry to develop and manufacture biotherapeutic medicines and vaccines cost-effectively. Our products and platform solutions are designed to meet the key challenges posed at every stage in the biomanufacturing process, delivering the desired product at the required purity and safety – all with fast development and integrated solutions in mind. Across the bioprocessing spectrum, our focus is on supporting you from idea to result.”

You can visit GE Healthcare at booth #3141 and Thermo Fisher Scientific at booth #3544 at INTERPHEX, March 18th—20th.

Get the most out of the show by connecting with us on TwitterFacebook and LinkedIn.

Image via GE Healthcare


Official blog of: INTERPHEX New York -
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s